Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sernova Corp. T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. It develops a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood, and neurological diseases with therapeutic cells placed into its implanted, prevascularized and scalable medical device.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSX:SVA)

Fundamentals Snapshot (TSX:SVA)

Current News (TSX:SVA)

Sernova Announces Executive Alignment and Appoints New Board Chair

GlobeNewswire 6 days ago

Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications

GlobeNewswire May 3, 2023

Sernova Corp. Announces Voting Results of the 2023 Annual General Meeting of Shareholders

TheNewsWire April 28, 2023

Concerned Shareholders of Sernova Corp. Wish to Thank All Shareholders

Canada NewsWire April 25, 2023

Successful Results Using Sernova's Cell Pouch System(TM) with Evotec's iPSC-Derived Islet-like Clusters for Type 1 Diabetes Presented at the 4th IPITA / HSCI / JDRF Summit

GlobeNewswire April 24, 2023

Sernova Reminds Shareholders to Vote FOR the Eight Management Director Nominees Using ONLY the WHITE Management Proxy

TheNewsWire April 21, 2023

Two Independent Proxy Advisory Firms, Including Glass Lewis & Co. LLC. Recommend Sernova's Shareholders Vote FOR all Management Nominees on Management's White Proxy

TheNewsWire April 18, 2023

Two Independent Proxy Advisory Firms, Including Glass Lewis & Co. LLC., Recommend Sernova's Shareholders Vote FOR all Management Nominees on Management's White Proxy

GlobeNewswire April 18, 2023

Concerned Shareholders of Sernova Corp. Stand by their Statements

Canada NewsWire April 17, 2023
View More News ››

Opinion & Analysis (TSX:SVA)

Buzz on the Bullboards: 2021 The Year of the Cannabis Comeback?

Stockhouse Editorial February 11, 2021

Buzz on the Bullboards: When Stocks Go Up … Must They Come Down?

Stockhouse Editorial January 28, 2021

Buzz on the Bullboards: A Deeper Look into New Energy Opportunities

Stockhouse Editorial January 21, 2021

HemAcure and Sernova, a big deal

Richard (Rick) Mills July 25, 2017

Sernova, diabetes and haemophilia

Rick Rule July 25, 2016

Sernova (V.SVA) puts focus on diabetes treatment device

Stockhouse Editorial May 16, 2014
View More Opinion ››

Bullboard Posts (TSX:SVA)

RE:RE:RE:Astrazeneca diabetes?

I laugh and SMH every time I see someone telling others not to post, or what to post. Lol. 
rixpix - May 4, 2023

GREAT NEWS..! TKO COMING

This might be the first step to a takeover by Astrazeneca... SVA is so cheap for what it has. Hold tight..its will be a big payday...
Tarbaby - May 4, 2023

RE:RE:Astrazeneca diabetes?

I have told you before I sell and buy this stock from time to time. I didnt hit the lows this time. Anyway seems there is still...
Ekenbullets - May 4, 2023

RE:Astrazeneca diabetes?

Too bad you sold off at the low though. Hopefully you still have a few shares for the gamble. 
BioTeck - May 4, 2023

Astrazeneca diabetes?

Good to see some risk reduction in Sernova stock. Would have been nice with a statement from Astrazenec in the press release...
Ekenbullets - May 3, 2023

SVA shares are up 25% in Germany!!

Volume is low but should pick up after the TSX opens. 
rixpix - May 3, 2023
View more Bullboard ››

NewRange Gold Corp.

NewRange Gold Corp.

Newrange Gold Corp is engaged in the district-scale exploration for precious metals in favorable jurisdictions including ...
View More »